Martin R Tremblay - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Martin R Tremblay

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Journal of Medicinal Chemistry|October 3, 2012

Synthetic silvestrol analogues as potent and selective protein synthesis inhibitorsTao Liu, Somarajan J Nair, André Lescarbeau, et al.

Journal of Medicinal Chemistry|October 10, 2008

Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.

ACS Medicinal Chemistry Letters|September 24, 2016

Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical CandidateCatherine A Evans, Tao Liu, André Lescarbeau, et al.

Journal of Medicinal Chemistry|August 14, 2020

Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1RBarbara Czako, Joseph R Marszalek, Jason P Burke, et al.

Journal of Medicinal Chemistry|June 16, 2009

Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926)Martin R Tremblay, André Lescarbeau, Michael J Grogan, et al.

Journal of Medicinal Chemistry|July 22, 2021

Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) ApoenzymeMatthew M Hamilton, Faika Mseeh, Timothy J McAfoos, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Journal of Medicinal Chemistry|October 3, 2012

Synthetic silvestrol analogues as potent and selective protein synthesis inhibitorsTao Liu, Somarajan J Nair, André Lescarbeau, et al.

Journal of Medicinal Chemistry|October 10, 2008

Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.

ACS Medicinal Chemistry Letters|September 24, 2016

Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical CandidateCatherine A Evans, Tao Liu, André Lescarbeau, et al.

Journal of Medicinal Chemistry|August 14, 2020

Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1RBarbara Czako, Joseph R Marszalek, Jason P Burke, et al.

Journal of Medicinal Chemistry|June 16, 2009

Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926)Martin R Tremblay, André Lescarbeau, Michael J Grogan, et al.

Journal of Medicinal Chemistry|July 22, 2021

Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) ApoenzymeMatthew M Hamilton, Faika Mseeh, Timothy J McAfoos, et al.

Pageof 2